FREE - Register to access one 3D Animation Video and Interactive Test from each of the
1 CME credits. This course is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) with European CME Credits (ECMEC®s) and by
the Postgraduate Institute for Medicine with
AMA PRA Category 1 Credits™.
3 CPD credits. This subject is approved by the Royal Society of Biology.
Targeted Therapies are used to attack specific proteins involved in signaling pathways related to the Carcinogenesis process. In Subject 09, we describe therapies such as Monoclonal Antibodies and Tyrosine Kinase Inhibitors directed at membrane receptors and particular intracellular proteins that play a role in DNA repair mechanisms, the Cell Cycle, Cell proliferation, Cell Death, Angiogenesis and Immune System, as well as how they can effectively readjust Carcinogenic mechanisms.
What will you learn?
With this course you
will learn about:
Tyrosine Kinase Inhibitors (TKIs).
Inhibitors of MAPK pathway and JAK/STAT pathway.
Inhibitors of other proteins involved in cell survival and proliferation (CDKs, PARP, mTORC1 and SMO), as well as, proteins involved in cell invasion (COX2).
Therapies targeting the immune system: cytokines analogs, bifunctional monoclonal antibodies, and immune checkpoints inhibitors.
Hormonal Targeted Therapies: inhibition of androgens and estrogens production and targeting of androgen and estrogen receptor.
Reset deadlines in accordance to your schedule. You will have 12 months to do the
course in your own pace.
Approx. 2 hours to complete
We recommend to dedicate 2 hours per week to complete the course in 1 week.
Start instantly and learn at your own schedule.
All course materials are in English. Customer attention: English and Spanish.